Of note, this signature comprises all the stromal genes (BGN, COL1A1, SFRP4) of the Oncotype DX Genomic Prostate Score, one of the most used genomic assays to guide PCa management. This evidence concerns the gene SFRP4 and posterior cortical atrophy.